Waldencast plc (WALD)

Market Cap	418.28M
Revenue (ttm)	240.38M
Net Income (ttm)	-70.64M
Shares Out	122.66M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,273
Open	3.300
Previous Close	3.240
Day's Range	3.180 - 3.450
52-Week Range	2.405 - 12.000
Beta	-0.53
Analysts	Strong Buy
Price Target	6.08 (+78.3%)
Earnings Date	Aug 27, 2024

About WALD

Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other phy...

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Mar 16, 2021
• Employees: 284
• Stock Exchange: NASDAQ
• Ticker Symbol: WALD
• Website: https://www.waldencast.com

Financial Performance

In 2023, Waldencast's revenue was $218.14 million, an increase of 31.30% compared to the previous year's $166.13 million. Losses were -$89.98 million, -5.85% less than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for WALD stock is "Strong Buy." The 12-month stock price forecast is $6.08, which is an increase of 78.30% from the latest price.

Price Target

$6.08

(78.30% upside)

Analyst Consensus: Strong Buy